Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia

Journal of Alzheimer's Disease

Volumn 30, Issue 1, 2012, Pages 75-82

  Geerlings, Mirjam I ^a   Brickman, Adam M ^b,c   Schupf, Nicole ^b,c,d   Devanand, Davangere P ^b   Luchsinger, José A ^b,d   Mayeux, Richard ^b,c,d   Small, Scott A ^b,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Columbia University ^*  (United States)

^c Vagelos College of Physicians and Surgeons   (United States)

^d Department of Medicine   (United States)

Author keywords

Antidepressants; brain; cohort; depressive symptoms; elderly; hippocampus; MRI; population based; white matter hyperintensity

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTICLE; BRAIN; BRAIN ATROPHY; BRAIN SIZE; CARDIOVASCULAR DISEASE; DEPRESSION; DIABETES MELLITUS; EDUCATION; ETHNICITY; FEMALE; GENDER; HEART DISEASE; HIPPOCAMPUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; WHITE MATTER;

EID: 84861485148     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-112009     Document Type: Article

References (39)

1. Beekman AT, Deeg DJ, van Tilburg T, Smit JH, Hooijer C, Van Tilburg W (1995) Major and minor depression in later life: A study of prevalence and risk factors. J Affect Disord 36, 65-75. (Pubitemid 26020975)
2. Beekman AT, Geerlings SW, Deeg DJ, Smit JH, Schoevers RS, de Beurs E, Braam AW, Penninx BW, Van Tilburg W (2002) The natural history of late-life depression: A 6-year prospective study in the community. Arch Gen Psychiatry 59, 605-611. (Pubitemid 34747240)
3. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60, 1119-1122. (Pubitemid 36975801)
4. Starkstein SE, Jorge R, Mizrahi R, Robinson RG (2005) The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry 162, 2086-2093. (Pubitemid 41598262)
5. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D (2006) Depression and risk for Alzheimer disease: Systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63, 530-538.
6. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R (2010) Depressive symptoms and risk of dementia: The Framingham Heart Study. Neurology 75, 35-41.
7. Dotson VM, Beydoun MA, Zonderman AB (2010) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
8. Byers AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol 7, 323-331.
9. Jorm AF (2001) History of depression as a risk factor for dementia: An updated review. Aust N Z J Psychiatry 35, 776-781. (Pubitemid 34048449)
10. Jacobson L, Sapolsky R (1991) The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 12, 118-134.
11. Knoops AJ, Gerritsen L, van der Graaf Y, Mali WP, Geerlings MI (2010) Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: The SMART-Medea study. Biol Psychiatry 67, 1191-1198.
12. O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N (2004) A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161, 2081-2090. (Pubitemid 39441410)
13. Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremner JD (2004) Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment. Biol Psychiatry 56, 101-112. (Pubitemid 38844785)
14. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Pen-ninx BW, Geerlings MI (2011) Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes-the SMART Medea study. Biol Psychiatry 70, 373-380.
15. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MMB (2000) Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 57, 1071-1076.
16. Steffens DC, Krishnan KR, Crump C, Burke GL (2002) Cere-brovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 33, 1636-1644. (Pubitemid 34619971)
17. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348, 1215-1222. (Pubitemid 36359297)
18. Alexopoulos GS (2006) The vascular depression hypothesis: 10 years later. Biol Psychiatry 60, 1304-1305. (Pubitemid 44838542)
19. Godin O, Dufouil C, Maillard P, Delcroix N, Mazoyer B, Crivello F, Alperovitch A, Tzourio C (2008) White matter lesions as a predictor of depression in the elderly: The 3C-Dijon study. Biol Psychiatry 63, 663-669. (Pubitemid 351329279)
20. Herrmann LL, Le MM, Ebmeier KP (2008) White matter hyperintensities in late life depression: A systematic review. J Neurol Neurosurg Psychiatry 79, 619-624. (Pubitemid 351829430)
21. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM (2008) History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 70, 1258-1264. (Pubitemid 351520949)
22. Dotson VM, Davatzikos C, Kraut MA, Resnick SM (2009) Depressive symptoms and brain volumes in older adults: A longitudinal magnetic resonance imaging study. J Psychiatry Neurosci 34, 367-375.
23. Goveas JS, Espeland MA, Hogan P, Dotson V, Tarima S, Coker LH, Ockene J, Brunner R, Woods NF, Wassertheil-Smoller S, Kotchen JM, Resnick S (2011) Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: The Women's Health Initiative MRI Study. J Affect Disord 132, 275-284.
24. den Heijer T, Tiemeier H, Luijendijk HJ, van der Lijn F, Koudstaal PJ, Hofman A, Breteler MM (2011) A study of the bidirectional association between hippocampal volume on magnetic resonance imaging and depression in the elderly. Biol Psychiatry 70, 191-197.
25. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, Merchant C, Lantigua R, Costa R, Stern Y, Mayeux R (2001) Incidence of AD in African-Americans, Caribbean Hispan-ics, and Caucasians in northern Manhattan. Neurology 56, 49-56.
26. Brickman AM, Schupf N, Manly JJ, Luchsinger JA, Andrews H, Tang MX, Reitz C, Small SA, Mayeux R, DeCarli C, Brown TR (2008) Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 65, 1053-1061.
27. Stern Y, Andrews H, Pittman J, Sano M, Tatemichi T, Lantigua R, Mayeux R (1992) Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol 49, 453-460
28. American psychiatric association. Diagnostic and statistical manual of mental disorders, fourth edition. American Psychiatric Association, Washington, DC, 1994.
29. DeCarli C, Maisog J, Murphy DG, Teichberg D, Rapoport SI, Horwitz B (1992) Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comput Assist Tomogr 16, 274-284.
30. DeCarli C, Murphy DG, Teichberg D, Campbell G, Sobering GS (1996) Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity. J Magn Reson Imaging 6, 519-528. (Pubitemid 126707488)
31. DeCarli C, Murphy DG, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI (1995) The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45, 2077-2084.
32. Brickman AM, Reitz C, Luchsinger JA, Manly JJ, Schupf N, Muraskin J, DeCarli C, Brown TR, Mayeux R (2010) Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol 67, 564-569.
33. Irwin M, Artin KH, Oxman MN (1999) Screening for depression in the older adult: Criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 159, 1701-1704. (Pubitemid 29379131)
34. Reitz C, Schupf N, Luchsinger JA, Brickman AM, Manly JJ, Andrews H, Tang MX, DeCarli C, Brown TR, Mayeux R (2009) Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol 66, 834-840.
35. Tanis KQ, Newton SS, Duman RS (2007) Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol Disord Drug Targets 6, 151-160. (Pubitemid 46681775)
36. Couillard-Despres S, Wuertinger C, Kandasamy M, Caioni M, Stadler K, Aigner R, Bogdahn U, Aigner L (2009) Ageing abolishes the effects of fluoxetine on neurogenesis. Mol Psychiatry 14, 856-864.
37. Sapolsky RM (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57, 925-935.
38. Krishnan MS, O'Brien JT, Firbank MJ, Pantoni L, Car-lucci G, Erkinjuntti T, Wallin A, Wahlund LO, Scheltens P, van Straaten EC, Inzitari D (2006) Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry 21, 983-989. (Pubitemid 44596394)
39. van den Heuvel DMJ, ten Dam VH, deCraen AJM, Admiraal-Behloul F, van Es ACGM, Palm WM, Spilt A, Bollen ELEM, Blauw GJ, Launer L, Westendorp RGJ, van Buchem MA on behalf of the PROSPER Study Group (2006) Measuring longitudinal white matter changes: Comparison of a visual rating scale with a volumetric measurement. AJNR Am J Neurora-diol 27, 875-878. (Pubitemid 44897739)